呋喃妥因
抗生素
肠道菌群
青霉素
微生物群
氟氯西林
粪便
医学
生物
肠道微生物群
阿莫西林
药方
基因组
药品
微生物学
头孢呋辛
作者
Gabriel Baldanzi,Anna Larsson,Sergi Sayols-Baixeras,Koen F. Dekkers,Ulf Hammar,Diem Nguyen,Tíscar Graells,Shafqat Ahmad,Camila Gazolla Volpiano,Guillaume Méric,Josef D. Järhult,Thomas Tängdén,Jonas F. Ludvigsson,Lars Lind,Johan Sundström,Karl Michaëlsson,Johan Ärnlöv,Beatrice Kennedy,Marju Orho-Melander,Tove Fall
出处
期刊:Nature Medicine
[Nature Portfolio]
日期:2026-03-11
卷期号:32 (4): 1351-1361
被引量:5
标识
DOI:10.1038/s41591-026-04284-y
摘要
Disruptions in gut microbiome are implicated in cardiometabolic disorders and other health outcomes. Antibiotics are known gut microbiome disruptors, but their long-term consequences remain underexplored. Here we combined individual-level data from the Swedish Prescribed Drug Register with fecal metagenomes of 14,979 adults to examine the association between oral antibiotic use over 8 years and gut microbiome. In multivariable confounder-adjusted regression models, antibiotic use <1 year before fecal sampling was associated with the greatest reduction in species diversity, but significant associations were also observed for use 1-4 and 4-8 years earlier. Clindamycin, fluoroquinolones and flucloxacillin accounted for most of the associations with the abundance of individual species. Use of these antibiotics 4-8 years earlier was associated with altered abundance of 10-15% of the species studied; penicillin V, extended-spectrum penicillins and nitrofurantoin were associated with only a few species. Similar results were found comparing one antibiotic course 4-8 years before sampling versus none in the past 8 years. These findings indicate that antibiotics may have long-lasting consequences for the gut microbiome.
科研通智能强力驱动
Strongly Powered by AbleSci AI